Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Boehringer Ingelheim
Citi
Daiichi Sankyo
Deloitte
Farmers Insurance
Covington
Harvard Business School

Generated: December 18, 2018

DrugPatentWatch Database Preview

LEVORPHANOL TARTRATE Drug Profile

« Back to Dashboard

Which patents cover Levorphanol Tartrate, and what generic alternatives are available?

Levorphanol Tartrate is a drug marketed by Sentynl Theraps Inc and is included in one NDA.

The generic ingredient in LEVORPHANOL TARTRATE is levorphanol tartrate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the levorphanol tartrate profile page.

Summary for LEVORPHANOL TARTRATE
Drug patent expirations by year for LEVORPHANOL TARTRATE
Pharmacology for LEVORPHANOL TARTRATE
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for LEVORPHANOL TARTRATE

US Patents and Regulatory Information for LEVORPHANOL TARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sentynl Theraps Inc LEVORPHANOL TARTRATE levorphanol tartrate TABLET;ORAL 074278-002 Jun 18, 2018 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sentynl Theraps Inc LEVORPHANOL TARTRATE levorphanol tartrate TABLET;ORAL 074278-001 Mar 31, 2000 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sentynl Theraps Inc LEVORPHANOL TARTRATE levorphanol tartrate TABLET;ORAL 074278-003 Jun 18, 2018 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Boehringer Ingelheim
Citi
Daiichi Sankyo
Deloitte
Farmers Insurance
Covington
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.